Global investment firm KKR beat Wall Street earnings estimates in Q2, delivering its largest monetization quarter in history as asset exits rebounded and management fee revenue surged. 📊 Key Financial Figures & Q2 Metrics Adjusted Net Income: $1.63 per share, comfortably topping analyst forecasts of $1.41. Management Fees: Jumped 25.5% YoY to $1.25 billion, providing...
Global investment firm KKR beat Wall Street earnings estimates in Q2, delivering its largest monetization quarter in history as asset exits rebounded and management fee revenue surged. 📊 Key Financial Figures & Q2 Metrics Adjusted Net Income: $1.63 per share, comfortably topping analyst forecasts of $1.41. Management Fees: Jumped 25.5% YoY to $1.25 billion, providing...
Pharma leader Eli Lilly and contract manufacturer Resilience have announced a joint $750 million investment to expand U.S. drug manufacturing capacity, strengthening domestic supply chains for key diabetes and obesity treatments. 📊 Key Investment & Operational Metrics Capital Commitment: $750 million allocated to expand pharmaceutical production infrastructure in Cincinnati, Ohio. Job Creation: Expected to generate...
Activist hedge fund Jana Partners is stepping up its campaign against fintech and payments giant Fiserv, urging management to initiate a comprehensive strategic review of its entire portfolio and overhaul its board of directors. 📊 Key Market Metrics & Background Valuation Collapse: Fiserv’s market cap has dropped to ~$30 billion, losing >50% of its value...
Goldman Sachs Asset Management has launched AlphaAI, a dedicated artificial intelligence investing platform aimed at driving investment returns across its public and private market portfolios. 📊 Key Structure & Strategic Leadership Platform Launch: AlphaAI launched to harness AI as both an industry disruptor and an investment force multiplier across public and private assets. Executive Leadership:...
CityFibre, the UK’s third-largest broadband network operator, is in talks with key shareholders to secure a £900 million ($1.20 billion) equity injection to fund aggressive strategic acquisitions. 📊 Key Capital & Operational Figures Target Equity Funding: £900 million ($1.20 billion) in proposed shareholder equity. Consortium Shareholders: Backed by major institutional investors including Goldman Sachs, Antin...